# ELEVANCE HEALTH, INC. (ELV) FY2025 Q3 P&L / Income Statement

- Company: ELEVANCE HEALTH, INC. (ELV)
- Period: 2025-07-01 to 2025-09-30
- Filing: Q3 FY2025 10-Q, filed 2025-10-21, accession number 0001156039-25-000136
- Page: https://plicit.ai/financials/elv/fy2025-q3-income-statement
- Chart image: https://plicit.ai/charts/elv-fy2025-q3-income-statement-sankey.png

## Chart details: Revenue by Product and Service (4 categories)

Income statement for 2025-07-01 through 2025-09-30. View: Product and service (4 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 50,711,000,000 US dollars
- **Total expenses**: 49,305,000,000 US dollars
- **Operating profit (calculated)**: 1,406,000,000 US dollars
- **Other income (expense), net (calculated)**: 0 US dollars
- **Income before income tax expense**: 1,406,000,000 US dollars
- **Income tax expense**: 219,000,000 US dollars
- **Net income**: 1,187,000,000 US dollars
- **Total operating revenue**: 50,087,000,000 US dollars
- **Net investment income**: 625,000,000 US dollars
- **Gain (loss) on sale of business**: 0 US dollars
- **Benefit expense**: 38,140,000,000 US dollars
- **Cost of products sold**: 5,380,000,000 US dollars
- **Operating expense**: 5,272,000,000 US dollars
- **Amortization of other intangible assets**: 162,000,000 US dollars
- **Interest expense**: 351,000,000 US dollars
- **Revenue before reconciliation (calculated)**: 50,712,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- **Net losses on financial instruments**: negative 1,000,000 US dollars. Reported reconciliation to consolidated revenue.

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
- Of which attributable to ELEVANCE HEALTH, INC.: $1.19 B; to noncontrolling interests: −$2.00 M.